by which these conditions retard fetal growth and the processes th at are responsible for the neonatal hypoglycemia are not completely understood.
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LcI [2DG]t dt o [glucose] MAT ERIALS AND METHODS
by which these conditions retard fetal growth and the processes th at are responsible for the neonatal hypoglycemia are not completely understood.
Maternal uterine art ery ligati on has frequentl y been used to study the consequences of redu ced uterine blood flow on the fetu s. Th is procedur e severely retard s fetal growth in the rat (4) (5) (6) (7) (8) (9) (10) . Previou s studies using this model have suggested that lim ited fetal nutrient availability and altered placental gaseous excha nge play important roles in the impairm ent of fetal growt h (5, 6) . Restricted glucose delivery to th e developing fetus lead s to low levels of glucose, th e primary fetal metabolic substrate, and insulin, an important fetal growt h ho rm one (6) . Uterine artery ligati on has been show n to pr odu ce fetal hypo xia, hypercapnia, and acidosis (6) , which likely affect both cellular metabolism and fetal growth. This m odel is also associated with reduced glycogen sto res and delayed inductio n of gluco neogenic en zyme s (7, 8) . Th ese processes also app ear to be importa nt facto rs in th e development of hypoglycem ia in the small-for-gestationa l-age newborn ( I I, 12). Ho wever, sm all-for-gestati on al-age human infants may ha ve increa sed metabolic rat es (13, 14) and rapid clearance ofi.v. adm inistered glucose (15, 16) , which could also contribute to the development of hypoglycemia.
The effects of uterine artery ligation on fetal GU rem ain unknown. Knowledge of th ese effects may further define th e mechanisms responsible for altered fetal glucose homeostasis, IUGR, and neonatal hyp oglycemia. Studies of fetal GU, however, would be incomplete if individual tissue responses to ut erine artery ligation were not co nside red. Fetal brain growth is m inimally, if at all, affected by th is procedure, whereas hepatic growth is mark edly impaired (4, 5) . Therefore, the effects on GU of individua l tissues may differ. Furthermore, these effects m ay change with tim e after the procedure. We therefore performed un ilateral uterine artery ligat ion s on pregnant rat s and measured GU of several major fetal tissues from fetu ses in the ligated and nonli gated ut erin e horn s at 24 and 48 h after ligation .
We used a modification of SokolofT's 2DG method to measu re fetal rat tissue G U (17) (18) (19) . 2DG is transported into th e cell and phosphorylated by hexokinase or glucokinase in a manner similar to glucose. Becau se of th e absence of the hydroxyl group at position 2, the phosph orylated product, 2DG6 P, is not furth er metab olized (17) . Th e accum ulation of 2DG6P within a tissue can therefore be used to determ ine G U . The standard equa tion to measure GU of a parti cular tissue after an i.v. puls e of 2DG is:
where [2DG6P] is the tissue con centration of 2DG6P at time T , 464 Abbreviations C U, glucose utilization IUCR, intrauterine growth retardation LC, lumped constant P k , placental discrimination constant 2DC, 2-deoxyglucose 2DC6P, 2-deoxyglucose-6-phosphate ABSTRACT. We studied the effects of maternal uterine artery ligation on fetal rat tissue glucose utilization (CU). Unilateral uterine artery ligations were performed on the 19th d of gestation (term 21.5 d) and 2-rHldeoxY-D-glucose was used to measure CU of placenta, liver, brain, muscle, kidney , and heart from fetuses in the ligated (IUCR) and nonligated (control) uterine horns 24 and 48 h after the procedure. At both periods, IUCR fetuses weighed significantly less and had lower fetal/maternal plasma glucose ratios than controls. Twent y-four h after ligation, placenta, liver, brain, and muscle from IUCR fetuses had lower relative C U rates than corre sponding tissues from control fetuses (p < 0.01 -0.05). However, at 48 h, IUCR liver, muscle, kidney, and heart had higher relative CU rates than control tissues (p < 0.01-0.05). The lower C U of IUCR fetal tissue s obser ved at 24 h postligation was likel y related to the acute decrease in fetal glucose availability. Other factors, such as hypoxemia and acidosis, that affect cellular metabolism may also have led to lower CU rates. The increase in C U by IUCR tissues at 48 h occurred despite a persistence of low fetal glucose concentrations and can be explained by either: 1) an attempt by IUCR fetal tissues to compensate for the persistently low plasma glucose; 2) an increased demand for metabolic fuel for repair processes; or 3) a less efficient use of glucose due to alterations in cellular respiration. We speculate that this increase in fetal tissue CU may be partially responsible for the supranormal glucose requirements seen in smallfor-gestational-age newborn s. (Pediatr Res 28: 464-468, 1990) Matern al hypertension , chronic renovascular diseases, and several other condit ions are associate d with redu ced uterine blood flow during pr egnan cy. Th ese conditions are associa ted with a high incidence of IUGR and increased fetal and neon atal m ortal ity (I , 2). In addi tion , growth-retarded neonates are at significant risk for neonatal hypoglycem ia (3) . The mechanisms
[2DG] and [glucose] are the plasma concentrat ions of 2DG and glucose, and LC is the lumped consta nt (20) .
LC is a correction factor th at accounts for differences of affinities and maximal velocities of tran sport and pho spho rylation between 20 G and glucose. Each tissue has a specific LC; however, due to techn ical limit ations, the LC of individual fetal rat tissues cann ot be determined. Th e above equation without th is correction facto r provides a measure of relative GU. In our study, we com pared relative G U rates of similar tissues from experimental and control fetuses on the assumption that the experimental procedure had not affected the LC.
Measurements of fetal tissue GU require knowled ge of th e fetal plasma concentrations of 2DG and glucose. How ever, one cannot sample fetal blood in the unanesthetized rat and, as anesthesia may alter glucose metab olism, measurem ent s of GU mu st be mad e in the awake anima l. Using the method of Leturqu e et at. ( 18, 19) , we established the relationship between fetal and mat ernal plasma concentrations of 2DG and glucose after a pulse of 2DG for each of the study and control groups of fetuses in anesthetized rats. Th is relationship is best expressed as a ratio, which has been term ed P k :
Once P, is known, relative GU rates of fetal tissues can be measured in the awake anima l using maternal arte rial plasma concentrations of 2DG and glucose and the fetal tissue concentrations of 2DG 6P:
Pk
[ I ] dt (ma terna l plasma) o g ucose Surgical procedure. Nine-wk-old pregnant Sprague-Dawley rats were obtained from Harlan Laboratories (Madison, WI), housed separately, and allowed free access to water and food. On d 19 of gestatio n (term 2 1.5 d), we anesthetized each mat ern al rat with int raperitoneal injections of 6 mg/kg xylazine and 30 mg/k g ketamine and made a vertical abdominal incision und er sterile conditions. For GU measurem ents, the left cervical uterine artery was ligated with a single silk suture. Th e right uterine horn was similarly man ipulated but the artery was not ligated . Th e left jugular vein and carotid artery were then cath eterized with sterile polyvinyl tubing. Rat s were excluded from the GU studies if they had fewer than four or greater than seven fetuses per uterine horn or a discrepancy of mor e than two fetu ses between uterine horn s.
For P, determ inati ons, bilateral uterine artery ligation s or sham surgeries were perform ed becau se eight or mor e fetal blood sampl es were required. Catheterizatio ns were done as in the GU studies. All animals were allowed to recover for 24 h before further testing.
Th is prot ocol was approved by the Animal Care Committees of No rthwestern University and Children's Mem orial Hospital.
Gtl. Relative GU rates of fetal tissues were measured at 24 a nd 48 h after ligation of the uterine artery . After a 3-to 5-h fast, each rat was placed in a snug but not overly tight restraint. On ce the rat was tranquil, 370 kBq (sp act 262.7 kBq/nmol) of e H] 2DG (New England Nuclear, Boston , MA) was injected th rough the ju gular catheter. Matern al blood ( 100 j.LL) was obtained through the arterial catheter at I, 3, 5, 10, IS, 20, 25, 30, 35, and 43 min after the injection. At 44 min , the mother was ane sthetized with 40 mg /kg i.v. pentobarbital and her abdominal wound was reopened . At 45 min , thre e fetuses from the mid-p ortion of each uterine horn were removed, decapit ated, frozen in their entirety in liquid nitr ogen , and weighed. All six fetuses were rem oved and frozen within 2 min . Approximately 100-mg portion s of the placenta (villous chorion) and liver, and the enti re heart , cerebral hemispheres, kidney, and hind limb mu scles were rem oved from each frozen fetu s and weighed. Tissues were placed in 0.5 mL I N NaOH, heated to 60°C until compl etely digested , and then neutralized with 0.5 mL I N HCl (21) . Tissue hornogenates were later assayed for [3H]2DG6P activity.
Pi. P, were also deter mi ned 24 and 48 h after bilateral uterin e art ery ligation s or sham surgery. We ane sthetized the maternal rat with 40 mg/k g i.v. pentobarbital, performed a tracheostom y, and ventilated the rat in a fractional inspired oxygen of 0.21 at 80 breaths/min with a tidal volume of 1.7 mL. The abd ominal wound was then reopened and covered with warm saline -soaked gauze. Care was taken not to man ipulate the uterine horn s in a way that would interfere with uterine blood flow. Body temperature was maintain ed with the use of a heatin g pad. At tim e 0, we injected 370 kBq of [3H]2DG into the jugular catheter. Mat ernal blood was collected at the same times as in the GU stud ies. Immediately after obtaining each maternal sampl e, a small hysterotom y was made and a single fetu s was exposed leaving the uteroplacent al-fetal circulatio n int act (22) . The fetal axillary art ery was severed and blood was collected in heparin ized cap illary tube s. Fetal blood was usually obtained at 2, 4, 6, II , 16, 2 1, 26, 31, 36, and 44 min after the 20 G injection.
A nalyses. Plasm a [ 3H]2D G activity . Materna l blood (from GU measurem ent s and P, determinat ion s) and fetal blood (from P, determination s) were centrifuged at 9000 x g. Fifty j. LL of plasm a from each sam ple were added to 5 mL of scintillation cocktail (Cytoscint, ICN , Cleveland, OH ) and counted for 10 min. Th e plasma glucose con centration of each sampl e was determined in duplicate (Beckma n Gluc ose Analyzer II).
Ti ssue F H]2DG6 P activity. To separate tissue 2DG from 2DG6 P, we used a method based on the prin ciple that although both 2DG and 2DG6 P are solub le in 5% HCl O. , only 2DG remains soluble in a Ba(OH h /ZnS04 mixture (23) . On e 400-j.LL aliquot of tissue homogenate was added to 1.0 mL of 5% HCI0 4 and a second 400-j.LL aliquot was add ed to 0.5 mL Ba(OH) 2 (Sigma Chem ical Co., St. Louis, MO), followed by the addition of 0.5 mL ZnSO. (Sigma). After centrifugatio n, 700 j. LL of each supernata nt was added to 20 mL of scintillation cocktail and counted for 10 min. Th e differen ce in radioactivity between the HCl04-and Ba(OH )2/ZnS04-treated sam ples was used as th e tissue [3H]20G6P activity.
Calculations . P, determ inat ions. Th e rat io of [3H]2DG activity to glucose concentration for each matern al and fetal plasma sample was plott ed versus time (Fig. I) . Th e area under th e maternal curve from tim e 0 to 45 min was obtained by establishing the best-fit curve using the double exponential eq uatio n: y = Ae'" + Ce o x + E; where A, B, C, D, and E are constants chosen by a curve-fitt ing program . The int egral of th e equ ation was then calculated. Because th e fetal plasma [3H]2DG activity did not peak immediately after the 2DG injection , the area und er th e fetal curve from time 0 to the peak [2D G]/[glucose] value was determined separa tely. Th e area under the rem ain ing fetal curve from the peak value to 45 min was calculated using the best-fit cur ve meth od. Th e ratio of the area und er the fetal curve to th e area und er the maternal curve is equi valent to the P k • GU m easurem ents. Th e ratio of [3H]2DG activity to glucose concentration for each matern al plasm a sam ple was plotted versus time . T he area under the curve from time 0 to 45 min was obta ined, as before, using the best-fit curv e method. Th e value of the inte gral was corrected by the previou sly dete rmined Pko The relat ive G U of a specific fetal tissue for a single experiment was calculated by dividing the average 2DG6 P activity of that tissue from the three fetu ses of either the ligated or non ligated uterine horn by the corrected value of the integral.
St atistical analysis. We used unpaired, one-t ailed t tests to determine differences between IUGR and contr ol fetal weights. Gr oup differences of Pk values and fetal/matern al glucose rati os were determ ined by anal ysis of varia nce. Paired, two-tailed t tests LUEDER AND OGATA DISCUSSION were used to analyze GU differences between IUGR and control fetal tissues. Data are presented as mean ± SEM.
We found a biphasic response of fetal rat tissue GU after ut erine arte ry ligation. At 24 h postligation, placent a, liver, cerebral hemispheres, and hind limb mu scle from IUGR fetuses had lower relative GU rates than the corresponding tissues from control fetuses. However, at 48 h, GU was higher in IUGR liver, hind limb muscle, kidney, and heart. All IUGR tissues dem onstrated an increase in GU , relative to control, from 24 to 48 h postligation , with liver and muscle showing the greatest changes. IUGR tissues dem onstrated an average decrease in GU of 8.2% at 24 h and an average increase of 22.2% at 48 h after uterine arte ry ligation.
Our results concur with two earlier studies. Nitzan and Groffman (9) found an increased uptake of 14C-glucose in vitro by IUGR liver slices but not by IUGR brain slices at term after uterine artery ligation in the rat. In a separate in vivo study, the y found a relatively greater uptake of 2DG by several IUGR rat fetal tissues 2 d after uterine artery ligation (5). However, because of their methodol ogy, they could not quantitate fetal tissue G U. Our results are also supported by reports of increased glucose disappearance rates in hypoglycemic IUGR hum an newborns (15, 16) . This observation has been considered to be the result of "growth-sparing" of metabolically active organs, e.g. brain and heart. Our data suggest that absolute increases in IUGR tissue GU may be partially responsible for these elevated glucose requi rements.
We used a modification of the 2DG method described by Leturque et a/. ( 18, 19) to measure relative GU rates of fetal rat tissue. In addition to the criteria described by Sokoloff et a/. (17) for the original 2DG method, two further assumptions must be made: 1) glucose-6-phosphatase activity of fetal tissues is negligible or, if present , is similar between IUGR and control fetuses; and 2) the LC of fetal tissues is not affected by uterine arte ry ligation .
Glu cose-6-phosphatase is only found in large concentrationin postn atal rat liver, kidney, and intestine (24) . Although glu cose-6-phosph atase is present in fetal rat liver and kidne y, its activity remains low until birth (24) (25) (26) . Small concentrations of this enzyme, however, may result in falsely low GU rates as calculated by the 2DG method (27) . Our observation of higher GU of IUGR liver and kidne y at 48 h postligation could have resulted from a delay in glucose-6-phosphatase induction not seen in controls. However, fetal hypoglycemia and hypoinsulinemia, as produced by maternal fasting or insulin infusion , increases glucose-6-phosphatase activity in fetal liver (28) . Inasmuch as maternal uterine artery ligation also produces fetal hypoglycemia and hypoinsulinemia, IUGR fetal tissues would be expected to have higher enzyme activity than controls, thus resulting in lower rather than higher GU rates. Althou gh the second assumption cannot be verified, it is doubtful that uterine artery ligation should have produced a change in the Km or Vmax of a tissue's transporter or hexokinase for 2DG without equall y affecting that for glucose.
The P k accounts for differences in 2DG and glucose concentrations between maternal and fetal plasma after th e administration of 2DG to the mother. The value of this ratio is influenced by at least three processes: 1 ) a lag period between the injection of 2DG into the maternal vein and its appearance in th e fetal circulation (Fig. 1); 2) a greater affinity of the glucose transport er for 2DG over glucose; and 3) a lesser affinity of placental hexokinase for 2DG . Th e first process will tend to decrease the value of P k , whereas the second and third pro cesses will tend to Fetal weight. At 24 h after ute rine arte ry ligation, IUGR and control fetuses weighed 3.02 ± 0.14 and 3.37 ± 0.13 g, respecti vely (p < 0.05). At 48 h, IUGR fetuses weighed 3.61 ± 0.11 g, whereas control fetuses weighed 4.70 ± 0.08 grams (p < 0.005).
P, and f etal matern al glucose.
Uterine artery ligation resulted in significantl y greater mean P k values at 24 and 48 h postligation (Table I) . Although maternal IUGR and control plasma glucose concentrations were similar, IUGR fetuses had significantly lower plasma glucose concentrations than controls at both periods, resulting in lower fetal/ maternal glucose ratios. Uterine artery ligation was associated with reductions in the fetal/maternal glucose ratio of 19.2% at 24 h and 14.4% at 48 h.
GU studies. At 24 h postligation, placenta, liver, brain , and mu scle from IUGR fetuses had lower relative GU rates than the respective tissues from control fetuses. Relative GU of kidn ey and heart were similar in IUGR and control fetuses (Fig. 2) .
At 48 h, IUGR liver, muscle, kidne y, and heart had higher relative GU rates than the control fetu ses. Relative GU rates of placenta and brain did not differ between IUGR and control fetuses at this time (Fig. 3) . increa se P k • We found significantl y higher P, values after uterine artery ligation . This finding may be explained by the production by the IUGR placenta of glucose transporters with relatively greater affinity for 2DG or hexokinases with relatively lower affinity for 2DG. Alternatively, with reduced uterine blood flow, a higher percentage of glucose and 2DG may have been extracted from the maternal circulation . This may have induced a change in the placental LC, thus explaining the higher P, values in IUGR fetuses. After 2DG administration to pregnant Wistar rats on d 19 of gestation , Leturque et al. (19) measured the ratio of the integrals of maternal to fetal blood 2DG/glucose, which is the inverse of our P k • They obtained a value of 0.87 ± 0.02, the inverse of which (1.15) compa res favorably with our 24 h control value. They also measured GU of placenta, liver, brain , muscle, and heart from d 19 fetuses during maternal hyperglycemic and euglycemic hyperinsulinemic clamp experiments (19, 20) . They found GU rates of their control fetal tissues somewhat higher than those we observed for our respective control tissues. This difference may be due to the use of a different rat stain or use of a different P, value. Several mechanisms may explain the differences in GU rates between IUGR and control tissues. The lower GU of IUGR tissues 24 h postligation is probabl y due to the acute decrease in fetal plasma glucose concentrations. Alterations in other factors that affect cellular metabolism such as hypoxia-induced reduction of cellular metaboli sm could also have affected GU .
The higher relative GU rates of IUGR tissues at 48 h postligation were not anticipated. They occurred despite a persistence of low fetal plasma glucose concent rations. In addition, we have previously documented low insulin levels in IUGR fetuses 48 h after uterin e artery ligation (6) . The mechani sms responsible for the parad oxical increase in uptake and phosphorylation of 2DG (and thus glucose) are not clear. This finding may reflect an adaptation or comp ensation by fetal tissues in response to persistently low glucose concentrations. By increasing the number of glucose transporters or the amount of hexokinase , fetal tissues would be more able to extract glucose from plasma . Other studies support this mechani sm. Rat skeletal muscle cells up-regulate their 2DG uptake and have higher levels of glucose transporter mRNA when exposed to low (2 mM) glucose (29) . Similarly, brains from chronically glucose-starved rats have elevated glucose transporter mRNA levels (30) .
The higher GU may also be the result of an increa sed dem and for metabolic fuel by IUGR tissues. Cellular death and structural damage are likely consequences of uterine artery ligation. Repair processes would require additional energy and thu s could account for the elevated rates of GU. Alternati vely, the increased demand for glucose may be explained by a decreased oxidation of carbons arising from glucose, which, in turn, is com pensated for by increased glycolysis. Maternal uterine artery ligation significantl y reduces the ATP/ ADP ratio and profoundly alters cytosolic and mitochondrial redox states in fetal liver (31) . These findings indicate a disrupti on of cellular respiration resulting in less ATP generated per unit glucose used. Because hexokinase , the rate-limiting enzyme of glycolysis, is inhibited by ATP and stim ulated by ADP , this process could lead to increased GU by IUG R fetal tissues.
Additional factors may contribute to the relatively higher GU by IUGR fetal tissues. Collateral uterine circulation may be developing by 48 h after ligation. Although serial measurements of uterin e/placental blood flow after uterine arte ry ligation are lacking, some investigators have found a persistence of reduced placental blood flow when expressed as mL/min at 3 and 4 d postligation (32, 33) . Higher fetal glucose concentrations and fetal/maternal glucose ratios were observed at 48 h postligation for both IUG R and control fetuses. Although the IUGR fetal/ maternal glucose ratio remain ed significantly lower than control , the increase in IUGR fetal glucose may reflect an improved availability of glucose that contributed to the higher GU rates of IUGR tissues. Although fetal insulin levels were not measured in our stud y, we have previously demonstrated low insulin concentrations in IUGR fetuses 48 h after ligation. This observation argues against the speculation of higher glucose availability and rules out the possibility of high insulin as a cause of the increased GU of IUGR tissues.
It should be noted that the GU of control liver decreases from d 20 to 21 (Figs. 2 and 3) . Thi s was not observed in IUG R liver and thus accounts for the relatively higher GU of IUGR liver at 48 h postligation. Th e cause of the lower GU of control liver at 48 h is not known but may reflect maturational processes such as completion of glycogen deposition.
IUGR neonates have been reported to have significantly increased energy requirements and are at risk of developing hypoglycemia compared with normall y grown infants (3). The development of hypoglycemia results in part from limit ed hepati c glycogen stores and diminished gluconeogenic capability ( I I, 12). We speculate that a carryover of the increased tissue GU from fetal to neonatal life may also contribute to the development of hypoglycemia and the increased energy requirements. 
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